At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 43 enrolled
Drug / intervention
Ketamine Hydrochloride +1 moredrug
Likely dose
Ketamine Hydrochloride 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Ketamine
University of Texas Southwestern Medical Center·interventional·Posted Aug 8, 2018·Updated Nov 26, 2021
In Brief
A Phase 4 clinical trial evaluating Ketamine Hydrochloride and Placebo for Hemorrhage and Healthy. Completed, enrolled 43 participants across 1 site.
Detailed Summary
The purpose of this project is to test how ketamine, an analgesics currently employed in the pre-hospital setting by the US Army, alters the capacity to tolerate a hemorrhagic insult in humans.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhage, Healthy
CountriesUnited States
CollaboratorsUnited States Department of Defense
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
First PostedAug 2018
Primary CompletionJun 2021
TodayJul 2026
First PostedAug 8, 2018
Enrollment StartJun 1, 2018
Primary CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 7.9 years ago
Interventions
Ketamine Hydrochloridedrug
A total of 20 mg of Ketamine Hydrochloride will be administered intravenously
Placeboother
Subjects will receive placebo